BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valenzuela A, Nandagopal S, Steen VD, Chung L. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis. Rheum Dis Clin North Am 2015;41:489-506. [PMID: 26210131 DOI: 10.1016/j.rdc.2015.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ross L, Moxey J, Nikpour M. Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review. Semin Arthritis Rheum 2021;51:299-309. [PMID: 33434765 DOI: 10.1016/j.semarthrit.2020.10.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ross L, Baron M, Nikpour M. The challenges and controversies of measuring disease activity in systemic sclerosis. Journal of Scleroderma and Related Disorders 2018;3:115-21. [DOI: 10.1177/2397198318765061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Wermuth PJ, Piera-velazquez S, Jimenez SA. Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis. Rheumatology 2018;57:1698-706. [DOI: 10.1093/rheumatology/kex404] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bruni C, Ross L. Cardiac involvement in systemic sclerosis: Getting to the heart of the matter. Best Pract Res Clin Rheumatol 2021;35:101668. [PMID: 33736950 DOI: 10.1016/j.berh.2021.101668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Morrisroe K, Huq M, Stevens W, Rabusa C, Proudman SM, Nikpour M; Australian Scleroderma Interest Group (ASIG). Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study. BMC Pulm Med 2016;16:134. [PMID: 27677579 DOI: 10.1186/s12890-016-0296-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
6 Mavrogeni SI, Schwitter J, Gargani L, Pepe A, Monti L, Allanore Y, Matucci-Cerinic M. Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls". Semin Arthritis Rheum 2017;47:79-85. [PMID: 28522072 DOI: 10.1016/j.semarthrit.2017.03.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
7 Al Otair HA, Idrees MM, Saleemi SA, Eltoukhy AM, Alhijji AA, Al Habeeb WA, Omair MA. Pulmonary arterial hypertension in Saudi patients with systemic sclerosis: Clinical and hemodynamic characteristics and mortality. Ann Thorac Med 2019;14:83-9. [PMID: 30745940 DOI: 10.4103/atm.ATM_33_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Guillén-Del-Castillo A, Meseguer ML, Fonollosa-Pla V, Giménez BS, Colunga-Argüelles D, Revilla-López E, Rubio-Rivas M, Ropero MJC, Argibay A, Mir JAB, Salas XP, Meñaca AM, Vuelta ABM, Padrón AL, Comet LS, Morera JAD, González-Echávarri C, Mombiela T, Ortego-Centeno N, González MM, Tolosa-Vilella C, Blanco I, Subías PE, Simeón-Aznar CP; RESCLE Consortium., REHAP Consortium. Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension. Sci Rep 2022;12:5289. [PMID: 35347225 DOI: 10.1038/s41598-022-09353-z] [Reference Citation Analysis]